News
CABI
4.750
NaN%
--
Cabbacis Inc. to Present at Noble Emerging Growth Equity Conference
Reuters · 01/29 18:21
Cabbacis to Present at the Noble Emerging Growth Equity Conference on February 4, 2026
Barchart · 01/29 12:21
Cabbacis Inc. Secures Two New U.S. Patents for Innovative Vaporizer Pod Technology
Reuters · 01/28 14:24
Cabbacis Inc. Granted U.S. Patent for Vaporizer Pods Containing Tobacco and Hemp
Reuters · 01/21 14:20
Cabbacis Granted U.S. Patent for Vaporizer Pods Containing Tobacco and Hemp
Barchart · 01/21 08:20
Cabbacis Inc. Hosts Live Investor Webinar on $7.5 Million Offering
Reuters · 01/14 16:20
Cabbacis to Host Live Webinar to Discuss $7.5 Million Offering and its Better Smoking and Vaping Alternatives
Barchart · 01/14 10:20
Cabbacis Inc. to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
Reuters · 10/06/2025 12:15
Cabbacis Inc. Reports First Half 2025 Results: Net Loss Widens to $735,560, EPS at Negative $0.12; No Revenue Reported
Reuters · 09/22/2025 15:51
CABBACIS PROVIDES FIRST HALF 2025 CORPORATE UPDATE
Reuters · 09/22/2025 15:51
Cabbacis Inc. Announces U.S. Patent Application for Novel Vaporizer Pods, Advancing Harm-Reduction Strategy
Reuters · 09/09/2025 12:45
Cabbacis Inc. Announces New Patent for Vaporizer Pods, Expanding its Global Intellectual Property Portfolio
Reuters · 07/17/2025 10:22
Cabbacis Granted U.S. Patent for Vaporizer Pods
Barchart · 07/17/2025 05:22
Cabbacis Inc. Announces Successful Clinical Trial Results for iBlend™ Cigarettes, Reducing Cravings and Carbon Monoxide Levels
Reuters · 07/15/2025 13:49
IBLEND™ IS HIGHLY RATED IN CLINICAL TRIAL AND SIGNIFICANTLY REDUCED CRAVINGS FOR USUAL BRAND CIGARETTES
Reuters · 07/15/2025 13:49
Cabbacis Receives SEC Notice of Qualification for Regulation A Offering
Barchart · 06/05/2025 16:16
More
Webull provides a variety of real-time CABI stock news. You can receive the latest news about Cabbacis Inc through multiple platforms. This information may help you make smarter investment decisions.
About CABI
Cabbacis Inc is a tobacco-product manufacturer focused on harm-reduction products. The Company is focused on commercializing patented harm-reduction tobacco products for smokers led by its flagship iBlend reduced-nicotine cigarettes and vaporizer pods in development. iBlend contains tobacco combined with non-intoxicating hemp to assist in smoking or vaping less, transitioning to less harmful tobacco products, and/or increasing quit attempts. It also plans to commercialize reduced-nicotine tobacco cigarettes and little cigars without hemp and vaporizer pods with conventional nicotine tobacco and hemp. The Company’s cigarettes and primary vaporizer pods in development include reduced-nicotine tobacco, which contains about 95 percent less nicotine than that of United States brands, and hemp, which contains less than 0.3 percent tetrahydrocannabinol (THC) and therefore is not intoxicating. It holds a global patent portfolio of 35 issued patents and various pending patent applications.